PULMONARY COMPLICATIONS AFTER FLUOSOL ADMINISTRATION TO PATIENTS WITH LIFE-THREATENING BLOOD-LOSS

被引:28
作者
POLICE, AM [1 ]
WAXMAN, K [1 ]
TOMINAGA, G [1 ]
机构
[1] UNIV CALIF IRVINE,IRVINE MED CTR,DEPT SURG,ORANGE,CA 92668
关键词
D O I
10.1097/00003246-198502000-00008
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
引用
收藏
页码:96 / 98
页数:3
相关论文
共 6 条
[1]  
GYER RP, 1968, FED P, V27, P384
[2]   CLINICAL-STUDIES OF A PERFLUOROCHEMICAL WHOLE-BLOOD SUBSTITUTE (FLUOSOL-DA) - SUMMARY OF 186 CASES [J].
MITSUNO, T ;
OHYANAGI, H ;
NAITO, R .
ANNALS OF SURGERY, 1982, 195 (01) :60-69
[3]  
OHYANAGI H, 1979, CLIN THER, V2, P306
[4]  
SLOVITER HA, 1975, FED PROC, V34, P1484
[5]   THE PREOPERATIVE TREATMENT OF SEVERELY ANEMIC PATIENTS WITH A PERFLUOROCHEMICAL OXYGEN-TRANSPORT FLUID, FLUOSOL-DA [J].
TREMPER, KK ;
FRIEDMAN, AE ;
LEVINE, EM ;
LAPIN, R ;
CAMARILLO, D .
NEW ENGLAND JOURNAL OF MEDICINE, 1982, 307 (05) :277-283
[6]   ACTIVATION OF PLASMA COMPLEMENT BY PERFLUOROCARBON ARTIFICIAL BLOOD - PROBABLE MECHANISM OF ADVERSE PULMONARY REACTIONS IN TREATED PATIENTS AND RATIONALE FOR CORTICOSTEROID PROPHYLAXIS [J].
VERCELLOTTI, GM ;
HAMMERSCHMIDT, DE ;
CRADDOCK, PR ;
JACOB, HS .
BLOOD, 1982, 59 (06) :1299-1304